**Question:** The primary site of action of triamterene and spironolactone is the -

A. Renal tubules
B. Liver
C. Gastrointestinal tract
D. Brain

**Core Concept:**

Triamterene and spironolactone are synthetic mineralocorticoid antagonists primarily used as diuretics and antihypertensive agents. They exert their effects through the modulation of the renin-angiotensin-aldosterone system (RAAS).

**Why the Correct Answer is Right:**

Triamterene and spironolactone primarily target the renal tubules, where they exert their pharmacological effects. These drugs are aldosterone antagonists, which means they block the actions of aldosterone, a hormone produced by the adrenal glands in response to low potassium levels and high blood pressure. Aldosterone promotes sodium and water retention, which leads to fluid retention and increased blood pressure.

By blocking aldosterone, triamterene and spironolactone increase urine output (diuresis) and decrease blood pressure, ultimately leading to the relief of symptoms associated with hypertension and edema. Their primary site of action is the renal tubules, where they interfere with the RAAS, thereby achieving their therapeutic effects.

**Why Each Wrong Option is Incorrect:**

A. Liver: Triamterene and spironolactone primarily act on the renal tubules, not the liver. Their effects are related to their modulation of the RAAS, not liver function.

B. Liver: Similar to option A, spironolactone and triamterene primarily affect the renal tubules and RAAS, not the liver. Their therapeutic actions are not related to liver function or enzymes.

C. Gastrointestinal tract: Triamterene and spironolactone exert their effects in the renal tubules and RAAS, not in the gastrointestinal tract. Their pharmacological actions are not related to digestion or absorption processes within the gut.

D. Brain: Triamterene and spironolactone primarily target the renal tubules and RAAS, not the brain. Their therapeutic actions are not associated with central nervous system effects.

**Clinical Pearl:**

In clinical practice, understanding the pharmacological actions of diuretics like triamterene and spironolactone is crucial for effective treatment of hypertension and edema. By targeting the renal tubules and RAAS, these medications help to reduce fluid retention and lower blood pressure, ultimately benefiting patients with these conditions.